Strategies to increase detection of hemochromatosis

Annals of Internal Medicine

Volumn 129, Issue 11, 1998, Pages 987-992

  McDonnell, Sharon M ^a   Witte, David L ^c   Cogswell, Mary E ^b   McIntyre, Rosemarie ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c Laboratory Control Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEMOCHROMATOSIS; HUMAN; LABORATORY; LEADERSHIP; MEDICAL EDUCATION; PHYSICIAN; POLICY; PRIORITY JOURNAL; PUBLIC HEALTH;

EID: 0032403960     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-11_part_2-199812011-00010     Document Type: Article

References (65)

1. Olynyk J, Hall P, Ahern M, Kwiatek R, Mackinnon M. Screening for genetic haemochromatosis in a rheumatology clinic. Aust N Z J Med. 1994; 24:22-5.
2. George DK, Evans RM, Crofton RW, Gunn IR. Testing for haemochromatosis in the diabetic clinic. Ann Clin Biochem. 1995;32:521-6.
3. Phelps G, Chapman I, Hall P, Braund W, Mackinnon M. Prevalence of genetic haemochromatosis among diabetic patients. Lancet. 1989;2:233-4.
4. MacSween RN, Scott AR. Hepatic cirrhosis: a clinico-pathological review of 520 cases. J Clin Pathol. 1973;26:936-42.
5. Gable CB. Hemochromatosis and dietary iron supplementation: implications from US mortality, morbidity, and health survey data. J Am Diet Assoc. 1992; 92:208-12.
6. Yang Q, McDonnell SM, Khoury MJ, Cono J, Parrish RG. Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of multiple-cause mortality data. Ann Intern Med. 1998;129:946-53.
7. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta. 1996;245:139-200.
8. Edwards CQ, Cartwright GE, Skolnick MH, Amos DB. Homozygosity for hemochromatosis: clinical manifestations. Ann Intern Med. 1980;93:519-25.
9. Adams PC, Valberg LS. Evolving expression of hereditary hemochromatosis. Semin Liver Dis. 1996;16:47-54.
10. Bradley LA, Haddow JE, Palomaki GE. Population screening for haemochromatosis: a unifying analysis of published intervention trials. J Med Screen. 1996;3:178-84.
11. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996;110:1107-19.
12. Cartwright GE. Hemochromatosis. In: Harrison's Principles of Internal Medicine. 7th ed. New York: McGraw-Hill; 1974:618-9.
13. Crosby WH. Hemochromatosis: current concepts and management. Hosp Pract (Off Ed). 1987;22:173-7, 181-92.
14. Bothwell TH. Hemochromatosis. In: Wyngaarden JB, Smith LH Jr, eds. Cecil's Textbook of Medicine. 16th ed. Philadelphia: WB Saunders; 1982:1128-31.
15. Powell LW, George DK, McDonnell SM, Kowdley KV. Diagnosis of hemochromatosis. Ann Intern Med. 1998;129:925-31.
16. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408.
17. Brook RH. Implementing medical guidelines. Lancet. 1995;346:132.
18. Soumerai SB, Avron J. Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA. 1990;263:549-56.
19. Pathman DE, Konrad TR, Freed GL, Freeman VA, Koch GG. The awareness-to-adherence model of the steps to clinical guideline compliance. The case of pediatric vaccine recommendations. Med Care. 1996;34:873-89.
20. Greco PJ, Eisenberg JM. Changing physicians' practices. N Engl J Med. 1993;329:1271-3.
21. Hillman AL. Financial incentives for physicians in HMOs. Is there a conflict of interest? N Engl J Med. 1987;317:1743-8.
22. Hillman AL, Pauly MV, Kerstein JJ. How do financial incentives affect physicians' clinical decisions and the financial performance of health maintenance organizations? N Engl J Med. 1989;321:86-92.
23. Kennedy M. Incorporating practice guidelines and clinical pathways into patient care. Qual Letter. 1995;7:1-24.
24. Burke W, Press N, McDonnell SM. Hemochromatosis: genetics helps to define a multifactorial disease. Clin Genet. 1998;54:1-9.
25. Woo B, Woo B, Cook EF, Weisberg M, Goldman L. Screening procedures in the asymptomatic adult. Comparison of physicians' recommendations, patients' desires, published guidelines, and actual practice. JAMA. 1985;254: 1480-4.
26. Wolfe YL. Case of the ceaseless fatigue. Prevention. 1997;July:88-91.
27. Wolfe YL. Ten medical tests you should consider for your health. Prevention. 1997;Sept:58-64.
28. CDC guidelines: improving the quality. Atlanta: Centers for Disease Control and Prevention; 1996.
29. Barton JC, Barton NH, Alford TJ. Diagnosis of hemochromatosis probands in a community hospital. Am J Med. 1998;103:498-503.
30. McDonnell SM, Phatak PD, Felitti V, Hover A, McClaren GD. Screening for hemochromatosis in primary care settings. Ann Intern Med. 1998;129: 962-70.
31. Clayton C, Hall P, Mackinnon M. Family screening for genetic haemochromatosis. What is the most effective method of contact? Med J Aust. 1993; 159:614-5.
32. Crawford R. The Iron Elephant. Glyndon, MD: Vida Publishing; 1990.
33. American Medical Association House of Delegates. Routine screening for iron overload/hemochromatosis. Resolution 525 (A-97). Chicago: American Med Assoc; 1997.
34. Yedidia MJ, Berry CA, Barr JK. Changes in physicians' attitudes toward AIDS during residency training: a longitudinal study of medical school graduates. J Health Soc Behav. 1996;37:179-91.
35. Cohen DI, Littenberg B, Wetzel C, Neuhauser D. Improving physician compliance with preventive medicine guidelines. Med Care. 1982;20:1040-5.
36. Everitt DE, Soumerai SB, Avorn J, Klapholz H, Wessels M. Changing surgical antimicrobial prophylaxis practices through education targeted at senior department leaders. Infect Control Hosp Epidemiol. 1990;11:578-83.
37. Lomas J, Enkin M, Anderson GM, Hannah WJ, Vayda E, Singer J. Opinion leaders vs audit and feedback to implement practice guidelines. Delivery after previous cesarean section. JAMA. 1991;265:2202-7.
38. Weingarten S, Stone E, Hayward R, Tunis S, Pelter M, Huang H, et al. The adoption of preventive care practices by primary care physicians: do actions match intentions? J Gen Intern Med. 1995;10:138-44.
39. Greer AL. The state of the art versus the state of the science. The diffusion of medical technologies into practice. Int J Technol Assess Health Care. 1988;4: 5-26.
40. Blaine JR. Screening for hemochromatosis encouraged. Mo Med. 1997;94: 612-3.
41. McLaren CE, Gordeuk VR, Looker AC, Hasselblad V, Edwards CQ, Griffen LM, et al. Prevalence of heterozygotes for hemochromatosis in the white population of the United States. Blood. 1995;86:2021-7.
42. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med. 1988;318:1355-62.
43. Iron overload disorders among Hispanics - San Diego, California, 1995. MMWR Morb Mortal Wkly Rep. 1996;45:991-3.
44. Barton JC, Edwards CQ, Bertoli LF, Shroyer TW, Hudson SL. Iron overload in African Americans. Am J Med. 1995;99:616-23.
45. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med. 1997;127:105-10.
46. Edwards CQ, Griffen LM, Kushner JP. The morbidity of hemochromatosis among clinically unselected homozygotes: preliminary report. In: Hershko C, Konijn AM, Aisen P, eds. Progress in Iron Research. New York: Plenum; 1994: 303-8.
47. Cogswell ME, McDonnell SM, Khoury MJ, Franks AL, Burke W, Brittenham G. Iron overload, public health, and genetics: evaluating the evidence for hemochromatosis screening. Ann Intern Med. 1998;129:971-80.
48. Burke W, Thomson E, Khoury M, McDonnell SM, Press N, Adams PC. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA. 1998;280:172-8.
49. Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ, et al. Management of hemochromatosis. Ann Intern Med. 1998;129: 932-9.
50. Becker MH, Maiman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care. 1975;13:10-24.
51. Overhage JM, Tierney WM, McDonald CJ. Computer reminders to implement preventive care guidelines for hospitalized patients. Arch Intern Med. 1996;156:1551-6.
52. Fletcher RH, Fletcher SW. Clinical practice guidelines [Editorial]. Ann Intern Med. 1990;113:645-6.
53. Kosecoff J, Kanouse DE, Rogers WH, McCloskey L, Winslow CM, Brook RH. Effects of the National Institutes of Health Consensus Development Program on physician practice. JAMA. 1987;258:2708-13.
54. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA. 1995;274:700-5.
55. Witte DL. Mild liver enzyme abnormalities: eliminating hemochromatosis as a cause. Clin Chem. 1997;43(8 pt 2):1535-8.
56. Gambino R. Routine screening for iron status. Hosp Pract (Off Ed). 1991; 26(Suppl 3):41-4.
57. Gunter E, McDonnell SM. Serum iron measures in hemochromatosis [Letter]. Clin Chem. 1998;44:361-2.
58. College of American Pathologists Chemistry Surveys, 1982 and 1997. Available from College of American Pathologists, 325 Waukegan Road, Northfield, IL 60093.
59. Phatak PD, Guzman G, Woll JE, Robeson A, Phelps CE. Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med. 1994; 154:769-76.
60. Adams PC, Gregor JC, Kertesz AE, Valberg LS. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database. Gastroenterology. 1995;109:177-88.
61. Clayton EW, Steinberg KK, Khoury MJ, Thomson E, Andrews L, Kahn MJ, et al. Informed consent for genetic research on stored tissue samples. JAMA. 1995;274:1786-92.
62. Witte DL, Kay BR. Hemochromatosis 1991. What will increased clinical screening mean for medical directors? J Insur Med. 1991;23:281-3.
63. Alper JS, Geller LN, Barash CI, Billings PR, Laden V, Natowicz MR. Genetic discrimination and screening for hemochromatosis. J Public Health Policy. 1994;15:345-58.
64. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA. 1997;277:973-6.
65. Witte DL. Wellness testing. Design and experience of an established program. Clin Lab Med, 1993;13:481-90.